We are live on ! Find out more
MRNA icon

Moderna

983 hedge funds and large institutions have $35B invested in Moderna in 2022 Q2 according to their latest regulatory filings, with 99 funds opening new positions, 348 increasing their positions, 355 reducing their positions, and 112 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more funds holding in top 10

Funds holding in top 10: 23 → 24 (+1)

0.24% less ownership

Funds ownership: 61.72% → 61.48% (-0.24%)

2% less call options, than puts

Call options by funds: $2.04B | Put options by funds: $2.07B

2% less repeat investments, than reductions

Existing positions increased: 348 | Existing positions reduced: 355

3% less funds holding

Funds holding: 1,010 → 983 (-27)

12% less first-time investments, than exits

New positions opened: 99 | Existing positions closed: 112

17% less capital inflows, than outflows

Capital inflows: $2.28B | Capital outflows: $2.73B

Holders
983
Holders Change
-27
Holders Change %
-2.67%
% of All Funds
16.48%
Holding in Top 10
24
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.35%
% of All Funds
0.4%
New
99
Increased
348
Reduced
355
Closed
112
Calls
$2.04​B
Puts
$2.07​B
Net Calls
-⁠$35.9​M
Net Calls Change
+$189​M

MRNA Hedge Fund Activity: Q2 2022 in Review

983 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q2 2022, worth a combined $35B — down 18% from $42.8B a quarter earlier.

Sellers outnumbered buyers: 112 funds closed out of MRNA and 99 opened new positions — a net loss of 13 holders — while 355 trimmed existing stakes and 348 added.

The largest buyer was Wellington Management Group, adding an estimated $581M. The largest seller was Flagship Pioneering, cutting an estimated $671M.

  • 983 institutional investors held Moderna (MRNA) as of Q2 2022, down from 1,010 in Q1 2022.
  • Funds reported $35B of Moderna stock for Q2 2022, down 18% quarter-over-quarter.
  • 99 funds opened new Moderna positions in Q2 2022 and 112 closed out, a net change of -13 holders.
  • The largest Moderna buyer in Q2 2022 was Wellington Management Group, an estimated $581M added.
  • The largest Moderna seller in Q2 2022 was Flagship Pioneering, an estimated $671M sold.

Based on aggregated 13F filings for Q2 2022.